PTGS2 and neoplasm: β-Sitosterol selectively inhibits the activity of the pro-inflammatory mediator COX-2 and reduces the levels of the oncogenic PGE2 in tumor tissues, blocking the promotion of tumor cell proliferation by the COX-2/PGE2 inflammatory axis (92).